MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1038/s41409-025-02727-7

Медицинская библиотека · Bone marrow transplantation · 2025

Impact of Wilms' tumor 1 gene (WT1) mutation on outcome of allogeneic hematopoietic-cell transplantation for acute myeloid leukemia: a retrospective multicenter cohort study from the ALWP/EBMT registry.

Nagler Arnon, Esteve Jordi, Galimard Jacques-Emmanuel, Sanz Jaime, Poire Xavier, Collin Matthew, Maertens Johan, Huang He, Itäla-Remes Maija, Halahleh Khalid, Pascual Cascon Maria Jesús, Chiusolo Patrizia, Griskevicius Laimonas, Kaare Ain, De Becker Ann, Jindra Pavel, Pérez-Simón Jose Antonio, Bazarbachi Ali, Brissot Eolia, Ciceri Fabio, Mohty Mohamad

СтатьяМногоцентровое исследованиеПеревод пока не подготовлен

Аннотация

We compared transplantation outcomes of AML patients with WT1 mutation (mWT1), identified by next-generation sequencing, to those of patients with wild-type WT1 AML (wtWT1). 703 patients were included, 50 with mWT1 and 653 with wtWT1. Patients with mWT1 were younger (median age: 45.6 vs. 56.4 years, p < 0.001), with a higher proportion of females (66% vs. 47.6%, p = 0.01), higher frequency of mutations in FLT3-ITD (38.3% vs. 21.7%, p = 0.01) and CEBPA (15.8% vs. 5.7%, p = 0.03). Donors were matched siblings in 30.6%, unrelated in 45.6%, and haploidentical in 22.1%. A higher percentage of mWT1 vs. wtWT1 patients received in vivo T-cell depletion (66% vs. 51%, p = 0.03) and 58% vs. 47.1% received myeloablative conditioning. 49 patients with mWT1 were matched to 127 wtWT1 patients in matched-pairs analysis. Outcomes (mWT1 vs. wtWT1) were not significantly different: relapse (2 y: 28.8% vs. 30.4%, HR: 1.14, p = 0.64), NRM (2 y: 15.5% vs. 9.9%, HR: 1.41, p = 0.49), LFS (2 y: 55.7% vs. 59.6%, HR: 1.21, p = 0.39), OS (2 y: 65.4% vs. 73.3%, p = 0.66), and chronic GVHD (2 y:24.3% vs. 25.4%, p = 0.95). In conclusion, WT1 mutation did not influence transplantation outcomes of AML patients in CR1.

Для цитирования: Nagler Arnon, Esteve Jordi, Galimard Jacques-Emmanuel, Sanz Jaime, Poire Xavier, Collin Matthew, Maertens Johan, Huang He, Itäla-Remes Maija, Halahleh Khalid, Pascual Cascon Maria Jesús, Chiusolo Patrizia, Griskevicius Laimonas, Kaare Ain, De Becker Ann, Jindra Pavel, Pérez-Simón Jose Antonio, Bazarbachi Ali, Brissot Eolia, Ciceri Fabio, Mohty Mohamad. Impact of Wilms' tumor 1 gene (WT1) mutation on outcome of allogeneic hematopoietic-cell transplantation for acute myeloid leukemia: a retrospective multicenter cohort study from the ALWP/EBMT registry.. Bone marrow transplantation. 2025. DOI: 10.1038/s41409-025-02727-7.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.